2024-06-29
Member Login Join GAFIO

Welcome To Gafio

Alliance vision

GAFIO's vision is to revolutionize global cancer care through AI and advanced medical technologies, aiming for a future where cancer is treatable and ultimately curable, with equitable access to innovative healthcare solutions.

Learn More

Welcome To Gafio

Mission and Goals

GAFIO's mission is to promote technological advancement and clinical application of AI in oncology, support interdisciplinary and international AI research, and foster excellence in cancer care through education, research, clinical practice, global collaboration, and advocacy.

Learn More

Background

Why was GAFIO established

The global incidence of cancer continues to rise, both in high-income countries and, especially, in low- and middle-income countries. In 2020, there were approximately 19.3 million newly diagnosed cancer cases, and 10.0 million cancer-related deaths worldwide. By 2050, the number of cancer cases is predicted to increase 77% to 35 million cases. Meanwhile, the economic cost for cancer treatment and care has been escalating 6%-9% annually, standing at around US$550 billion as of 2020. Moreover, geographic and economic barriers result in significant disparities in cancer survival rates between high-, middle- and low-income countries, for instance 67% in the US, 50% in India, and as low as 30% in sub-Saharan Africa. The escalating cost and complexity of cancer treatment necessitate a radical transformation in cancer care.

19.3 M

diagnosed cancer

10.0 M

related deaths

550 B USD

economic cost

9.0 %

escalating annually

GAFIO offers three types

Membership Types

Professional Background: Individuals applying for membership should have a background or interest in oncology, informatics, artificial intelligence, or related fields.
Qualifications: Applicants may be required to hold a bachelor's degree or higher in a relevant field, such as medicine, informatics, engineering, or related disciplines.
Commitment to GAFIO’s Mission: Prospective members should support GAFIO's mission and goals, which often involve advancing oncology, AI, and patient care through education, research, and collaboration.
Relevant Experience: While not always mandatory, having professional experience or involvement in oncology or AI-related activities can strengthen an individual's application for membership.

Relevant Background:  Open to residents, fellows, and students enrolled in relevant undergraduate, graduate, doctoral, post-doctoral, or resident training programs.
Commitment to GAFIO’s Mission: Prospective members should support GAFIO's mission and goals, which often involve advancing oncology, AI, and patient care through education, research, and collaboration.

Organizational Profile: Corporate members are typically entities such as hospitals, medical institutions, research organizations, and companies involved in healthcare, oncology, AI, or related industries.
Commitment to GAFIO's Mission: Similar to individual members, corporate members should align with GAFIO's mission and goals, especially in areas related to oncology, AI, and healthcare innovation.
Legal Entity Status: Corporate members must have legal entity qualifications or represent social groups with an interest in oncology, AI, or related social welfare activities.
Financial Commitment: Corporate members may be required to pay membership dues or fees based on their organizational size or membership tier.

Latest News

5/27/2026
Intelligent Oncology Officially Indexed in Scopus

Recently, the Editorial Office of Intelligent Oncology received a notification that the journal has been officially indexed in Scopus, the world's largest abstract and citation database.

Read More
5/19/2026
Multiscale Residual Dense Fusion Network Achieves Sharper, Faster Nuclear Medical Image Fusion

A study published in Intelligent Oncology introduces MRDFN, a multiscale residual dense fusion network that fuses multimodal medical images in just 0.07 seconds per pair while achieving 2.0× the average gradient of competing algorithms — promising a major boost for multimodal diagnosis.

Read More
5/10/2026
Machine Learning Decodes the “Gene Conversation” Network in Adrenocortical Carcinoma: A New Approach from a Columbia University Scholar

A new study published in Intelligent Oncology presents a machine learning-driven integrative framework to systematically decode the miRNA-mRNA ceRNA regulatory network in adrenocortical carcinoma (ACC), offering fresh insights into biomarker discovery and target prioritization for this rare malignancy.

Read More

Becoming a member

If you have a common vision with us, join us

Image

Please fill out the form

Fill in this information to help us understand you and create a private profile for you.

Email available
Email unavailable
Get
Verification code required
Password required
Confirm password required
Please select country or region
Please select member type
First Name required
Last/Family Name required
Please select gender
Please select Academic Degree
Affiliation required
Major Focus required
Cancer Subspecialties required

Our vision is to democratize cancer care through AI, aiming for a future where cancer is universally curable.

Useful Links

Home News Donation Journal Research Resources

News

Contact us

If you need any assistance, please send us an email and we will reply to you as soon as possible.

office@gafio.org
GAFIO_01
GAFIO_02
Copyright © 2024.Gafio All rights reserved.